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CPI and CPI are two canine isolates of simian virus 5 (SV5). CPI was originally isolated from the cerebrospinal fluid of
a dog with temporary posterior paralysis and CPI was recovered at 12 days p.i. from the brain tissue of a dog experimentally
infected with CPI. We have previously shown that the V protein of SV5 blocks interferon (IFN) signalling by targeting STAT1
for degradation. Here we report that whilst CPI targets STAT1 for degradation, CPI fails to and as a consequence, CPI
blocks IFN signalling but CPI does not. Three amino acid differences in the P/V N-terminal common domain of the V protein
are responsible for the observed difference in the abilities of CPI and CPI to block IFN signalling. In cells persistently
infected with CPI the virus may become repressed in response to IFN, under which circumstances virus glycoproteins are
lost from the surface of infected cells and virus nucleocapsid proteins accumulate in cytoplasmic inclusion bodies. We
suggest that in vivo cells infected with IFN-resistant viruses (in which there would be continuous virus protein synthesis) may
be more susceptible to killing by cytotoxic T cells than cells infected with IFN-sensitive viruses (in which virus proteinINTRODUCTION
The ability to produce and respond to interferon (IFN)
is central to the immune control of virus infections in vivo.
However, this is not an all or nothing response as viruses
have evolved a great variety of strategies to circumvent
the antiviral responses induced by IFNs. Thus, viruses
may inhibit the production of IFN, block inter- and intra-
cellular IFN signalling, or block the action of IFN-induced
proteins, such as PKR or oligo(A) synthetase, with anti-
viral activity (Goodbourn et al., 2000; Levy and Garcia-
Sastre, 2001). The biological activities of IFNs are initi-
ated by binding to their cognate receptors, which leads
to the activation of receptor-associated tyrosine kinase.
In the case of type I IFNs (IFN-/), the activated kinases
phosphorylate STAT1 and STAT2, which as a conse-
quence form heterodimers that enter the nucleus and
associate with p48 to form the ISGF3 complex that acti-
vates the transcription of type I IFN-responsive genes. In
an analogous but distinct pathway, following the binding
of type II IFN (IFN-) to its cognate receptor, the associ-
ated tyrosine kinases phosphorylate STAT1 (but not
STAT2), which forms homodimers, termed GAF com-
plexes, that activate type II IFN-responsive genes (for
reviews see Stark et al., 1998; Goodbourn et al., 2000;© 2002 Elsevier Science (USA)
All rights reserved.Levy and Garcia-Sastre, 2001). A common strategy em-
ployed by many paramyxovures to circumvent the IFN
response is to block the IFN-induced signal transduction
pathways within infected cells, although they achieve
this by distinct molecular mechanisms (Didcock et al.,
1999a,b; Garcin et al., 2000; Gotoh et al., 1999; Kato et al.,
2001; Parisien et al., 2001; Young et al., 2000; Kubota et
al., 2001; Takeuchi et al., 2001; Komatsu et al., 2000). For
example, simian virus 5 (SV5) blocks IFN signalling by
targeting STAT1 for degradation (Didcock et al., 1999b),
whilst human parainfluenza virus type 2 targets STAT2 for
degradation (Young et al., 2000; Parisien et al., 2001). In
contrast, although both Sendai virus and human parain-
fluenza virus type 3 block type I and type II IFN signalling
they achieve this by methods that do not necessarily
require the degradation of either STAT1 or STAT2 (Young
et al., 2000; Garcin et al., 2000; Takeuchi et al., 2001).
The genome of SV5, a prototype species of the rubu-
lavirus subfamily, contains seven genes: the nucleo-
protein (NP), V/phosphoprotein (V/P), matrix (M), fusion
(F), small hydrophobic (SH), haemagglutinin–neuramini-
dase (HN), and large (L) genes (for reviews on the mo-
lecular biology of Paramyxoviruses see Lamb and Kola-
kofsky, 2001). The V/P gene codes for two distinct pro-
teins, V and P, which have identical amino-terminal
domains but different carboxy-terminal domains. Co-
transcriptional insertion of two nontemplated G residuessynthesis was repressed), and a model of virus persist
IFN-resistant and IFN-sensitive viruses depending upon the
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unique C-terminus of the P and V proteins (Thomas et al.,
1988). One of the major roles of the multifunctional V
protein is to target STAT1 for degradation (Didcock et al.,
1999b; Young et al., 2001). In addition, V binds the 127-
kDa subunit of UV DNA damage binding protein (Lin et
al., 1998), thereby delaying the cell cycle to the possible
advantage of virus replication (Lin and Lamb, 2000). V
also binds soluble, but not polymeric, NP and thus may
have a role to play in the control of virus encapsidation
(Randall and Bermingham, 1996).
SV5 has been isolated from a number of species,
including man, monkey, and dog (for reviews see Hsiung,
1972; Randall and Russell, 1991; Southern et al., 1990).
Furthermore, the ability of SV5 to block IFN signalling is
also species-specific and indeed this may be one con-
straint which prevents viruses crossing species barriers
(Didcock et al., 1999a). Thus, whilst SV5 blocks IFN
signalling in monkey, human, and dog cells, natural iso-
lates do not block IFN signalling in murine cells, and the
virus is nonpathogenic in mice (Didcock et al., 1999a;
Young et al., 2001). An isolate, termed SV5-mci2, was
generated by continuous passage of SV5 in murine cells.
This virus had mutations including an asparagine (N) to
aspartic acid (D) substitution at position 100 in the V
protein, which resulted in the ability of the virus to block
IFN signalling in murine cells. Furthermore, a recombi-
nant virus was constructed that differed from the paren-
tal W3 strain only by the N to D substitution in P/V, termed
rSV5-V/P N100D, and that also blocked IFN signalling in
murine cells (Young et al., 2001). The N to D substitution
also abolished the binding of the SV5-P-k monoclonal
antibody (mAb) to the P or V proteins of mci2 and rSV5-
V/P N100D. Intriguingly, the same mAb was the only mAb,
in a panel of over 50, that could distinguish between two
related canine isolates of SV5, termed CPI and CPI
(Southern et al., 1990).
The CPI strain of SV5 was isolated from the cerebro-
spinal fluid of a dog with temporary posterior paralysis
and has been further studied as a neurotropic strain of
SV5 (Evermann et al., 1980; Baumga¨rtner et al., 1981,
1982). The CPI strain of SV5 was isolated from a gno-
tobiotic dog experimentally infected with CPI 12 days
p.i. (Baumga¨rtner et al., 1987). Characterisation of CPI
and CPI revealed biological and phenotypic differences
between these two isolates. Thus, for example, CPI is
attenuated in ferrets compared to CPI (Baumga¨rtner et
al., 1991) and in tissue culture cells more readily estab-
lishes persistent infections (Baumga¨rtner et al., 1987).
Here we demonstrate that whilst CPI degrades STAT1
and blocks IFN signalling in human and canine cells,
CPI does not. We discuss how CPI may have been
selected in vivo and present a general model of how
paramyxoviruses may establish persistent infections in
vivo.
RESULTS
CPI fails to degrade STAT1 and block IFN signalling
We have previously shown that a single N to D sub-
stitution at position 100 in the V protein of the W3 strain
of SV5 differentiates its ability to block IFN signalling in
human and murine cells (Young et al., 2001); since this
amino acid substitution mapped to the binding site of the
mAb SV5-Pk that distinguished between the CPI and
CPI strains of SV5 (Southern et al., 1990), we examined
the ability of CPI and CPI to degrade STAT1 in human,
canine, and murine cells. CPI behaved exactly like the
W3 strain, inducing the degradation of STAT1 in human
and canine cells but not in murine cells (Fig. 1, left). In
striking contrast, CPI failed to target STAT1 for degra-
dation in human, dog, or murine cells.
Comparative sequence analysis of the V genes of W3,
CPI, and CPI showed that there are three amino acid
differences between the V proteins of W3 and CPI that
all reside in the P/V N-terminal common domain; CPI
has three additional amino acid substitutions, also all
FIG. 1. Left: STAT1 levels in human (a), canine (b), or murine (c)
mock-infected cells cultured in the presence () or absence () of
exogenous IFN for 24 h or in cells infected with the W3, CPI, or CPI
strains of SV5. Total cell lysates of infected cells at 24 h p.i. were
electrophoresed through 10% PAGs prior to immunoblot analysis. Right:
Comparison of the ability of the V proteins of CPI and CPI to block
IFN signalling in human (a), canine (b), and murine cells (c). Cells were
transfected with a plasmid that contained the luciferase gene under the
control of an IFN-/-responsive promoter, together with one of pE-
Flink2 (control), pEF.W3/CPI/V (CPI), or pEF.W3/CPI/V (CPI) plas-
mids. Also included in the transfection mix was the plasmid pJATlacZ,
in which the lacZ gene is under the control of the rat -actin promoter.
At 44 h p.i. the culture medium was supplemented with IFN (IFN) or
left untreated (IFN). Four hours after induction with IFN, the cells were
lysed and luciferase activity was measured (relative light units) and
normalised to -galactosidase activity.
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located within the N-terminal V/P common domain (ty-
rosine to histidine at residue 26 and leucine to proline at
residues 50 and 102; Fig. 2). In order to confirm that the
amino acid differences in the V proteins of CPI and
CPI were responsible for their differing abilities to block
IFN signalling, the appropriate regions containing the
mutations of V/P genes were cloned into the W3 back-
bone of V by generating the plasmids pEF.W3/CPI/V and
pEF.W3/CPI/V, using the strategy outlined in Fig. 2. Hu-
man (2fTGH), canine (MDCK), and murine (BF) cells were
cotransfected with the appropriate plasmids together
with a type I IFN-responsive (ISRE) luciferase reporter
plasmid. At 44 h posttransfection, the cells were induced
with type I IFN and lysed 4 h later and the relative
luciferase activities determined. These results clearly
demonstrated that the V protein of CPI blocks IFN
signalling in human and canine cells, but not in murine
cells. However, CPI V failed to block IFN signalling in
any of the cells (Fig. 1, right).
Relative contribution of the three amino acid
substitutions in the N-terminal domain of the V
protein of CPI to loss of function
To compare the relative contributions of the three
amino acid substitutions in the failure of CPI to block
IFN signalling, the CPI mutations were reintroduced
individually or in pairwise combinations into the V
gene of CPI by site-directed mutagenesis, generating
the plasmids pEF.W3/CPI/V-(Y26H), -(L50P), -(L102P),
-(Y26H/L50P), -(L50P/L102P), and -(Y26H/L102P). V pro-
teins expressed from the resulting plasmids were tested
for their ability to block IFN signalling in the type I IFN
luciferase reporter assays using 2fTGH cells. Of the
single amino acid changes, only the L to P mutation at
position 50 had any effect on V function (Fig. 3). However,
this single amino acid substitution only partially abol-
ished the ability of V to block IFN signalling. When
placed in combination with second amino acid changes
at either position 26 or position 102, the block to signal-
ling was further impaired, but still not as disabled as that
seen for pEF.W3/CPI/V, suggesting that all three amino
acid changes are required to abolish IFN signalling in
the context of the CPI V protein. Interestingly, when the
amino acids 26 and 102 in CPI were changed to CPI
FIG. 3. Relative contributions of the different mutations in the V
protein of CPI in reducing the ability of V to block IFN signalling.
2fTGH cells were transfected with a plasmid that contained the lucif-
erase gene under the control of an IFN-/-responsive promoter,
together with pEFlink2 (control), pEF.W3/CPI/V (CPI), pEF.W3/CPI/V
(CPI), or pEF.W3/CPI/V-(Y26H), -(L50P), -(L102P), -(Y26H/L50P),
-(L50P/L102P), or -(Y26H/L102P) plasmid. Also included in the transfec-
tion mix was the plasmid pJATlacZ. At 44 h p.i. the culture medium was
supplemented with IFN (IFN) or left untreated (IFN). Four hours
after induction with IFN, the cells were lysed and luciferase activity was
measured (relative light units) and normalised to -galactosidase ac-
tivity. The names of the plasmids refer to CPI mutations substituted
into the CPI backbone. Thus, Y26H refers a tyrosine (Y) to histidine (H)
substitution at amino acid position 26 in the CPI V protein (see Fig. 2).
It should be noted that replacing two of the three amino acid in the
CPI V protein with the CPI mutations is the same as substituting a
single amino acid in the third position of CPI V protein with the CPI
equivalent [e.g., the double mutation pEF.W3/CPI/V-(Y26H/L102P)
shown could have been written pEF.W3/CPI/V (P50L)].
FIG. 2. (a) Schematic diagram detailing the positions of amino acid
differences between the V proteins of W3, CPI, CPI, and mci-2
superimposed on the P/V gene of the viruses. The cloning strategy for
generating pEF.W3/CPI/V, pEF.W3/CPI/V, and pEF.mci-2/V plasmids is
illustrated. The P/V genes from CPI-, CPI-, and mci-2-infected cells
were amplified by PCR, cleaved with BamHI, and used to replace the
BamHI fragment (light grey) in pEF.W3/V. Also shown are the positions
of the Pk epitope, the editing site, and the V stop codon. (b) Table
documenting the nucleotide differences between the V genes of W3,
CPI, and CPI. Also shown are the amino acid differences of both the
V and the P proteins. No changes, or silent changes, are illustrated in
light grey, whilst changes which result in amino acid substitutions are
illustrated in black. Note that nucleotide changes at positions 173/174
and 183/184 affect the two ORFs of the gene differently, as they are
silent in the V ORF (light grey) but have an effect on the P ORF (black).
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[i.e., -(Y26H/L102P), which is the same thing as changing
the amino acid at position 50 in CPI (P) to CPI (L)] the
resultant V protein was able to efficiently block IFN
signalling. Similar results were obtained using MDCK
cells (data not shown), indicating that the various muta-
tions did not have clear differential effects in human and
canine cells.
Relative rates of virus protein synthesis in canine
cells infected with CPI and CPI
Given that CPI blocks IFN signalling but CPI fails to,
it was of interest to compare the efficiency of replication
of CPI and CPI in cells that produce and respond to
IFN. Canine (MDCK) cells were infected with CPI or
CPI at a high m.o.i. and metabolically labelled with
[35S]methionine at 10–12, 16–18, 22–24, and 46–48 h p.i.
The cells were then lysed and HN, NP, F, P, and M were
immune precipitated with a pool of mAbs specific for
these proteins. The proteins in the total cell extracts (Fig.
4a) and the immune precipitates (Fig. 4b) were subse-
quently analysed by SDS–PAGE and the profiles visual-
ised by phosphoimager analysis. There was a small but
significant increase in the amount of virus protein syn-
thesis in cells infected with CPI compared to CPI at 18
and 24 h p.i. However, no significant differences were
observed at 12 or 48 h p.i.
Cell-to-cell spread of CPI and CPI in presence and
absence of IFN following a low m.o.i.
The above experiments were carried out on cells that
had been infected at high m.o.i. and thus relied on the
cells producing and responding rapidly to IFN. To exam-
ine the effects of IFN on the cell-to-cell spread of CPI or
CPI following low m.o.i., MDCK cells were infected at
0.01 pfu/cell and the culture medium was or was not
supplemented with IFN at 12 h p.i. The addition of IFN
was delayed until 12 h p.i. so as not to interfere with the
initial replication of virus. At 24 and 72 h p.i., virus-
infected cells were examined by immunofluorescence
using a pool of anti-NP and anti-P mAbs (Fig. 5). In the
absence of exogenous IFN, both CPI and CPI spread
rapidly through the monolayer such that all the cells
were infected by 72 h p.i. The addition of exogenous IFN
completely blocked the spread of CPI. In contrast, IFN
delayed but did not prevent the spread of CPI from cell
to cell, such that by 72 h p.i. approximately 30% of the
cells in monolayers infected with CPI were infected.
A further difference between CPI and CPI was noted
in the distribution of the NP and P proteins. In the ab-
sence of exogenous IFN at 72 h p.i., the NP and P
proteins both were observed diffusely distributed
throughout the cell and also in cytoplasmic inclusion
bodies both in cells infected with CPI and in cells
infected with CPI (although the cytoplasmic inclusion
bodies were more noticeable in cells infected with CPI).
However, in the presence of IFN in cells infected with
CPI the NP and P proteins were primarily located in
cytoplasmic inclusion bodies with very little diffuse cyto-
plasmic fluorescence. In contrast, in the majority of cells
infected with CPI in the presence of IFN there was both
diffuse cytoplasmic distribution of the NP and P proteins
and inclusion bodies (data not shown; see also below).
Characterisation of cells persistently infected with
CPI and CPI
The W3 strain of SV5 does not block IFN signalling in
murine cells (Didcock et al., 1999a). Nevertheless, follow-
ing infection of murine cells with W3 at high m.o.i.,
although all the cells initially make large amounts of
virus protein, once the cells begin to produce and re-
spond to IFN the majority of cells clear the virus infec-
FIG. 4. SDS–PAGE analysis of 35S-labelled total cell extracts (a) or
viral polypeptides that were immune precipitated with mAbs specific
for the SV5 HN, NP, F, P/V, and M proteins from soluble antigen extracts
(b) of MDCK cells that had been mock infected or infected with CPI or
CPI. The cell monolayers were metabolically labelled with [35S]methi-
onine for 2 h prior to harvesting at 12, 18, 24, and 48 h p.i. Mock-infected
cells were labelled for 2 h at 22 h p.i. Polypeptides were separated
through 12% PAGs.
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tion. Thereafter, in those cells which remain infected, the
virus fluxes between active and repressed states in re-
sponse to cell passage and the local production of IFN
(Young et al., 1997). Since CPI also fails to block IFN
signalling, a series of experiments was carried out to
determine whether CPI behaved in canine cells similar
to the W3 strain in murine cells. MDCK cells were in-
fected at a high m.o.i. and passaged. At 1 and 20 days p.i.
monolayers were immunostained with a pool of anti-NP
and anti-P mAbs (Fig. 6). At 1 day p.i. all the cells were
infected with either CPI or CPI. However, by 20 days
p.i., whilst all the cells remained infected with CPI, a
significant proportion (approx 40%) of cells infected with
CPI had cleared the infection. Again there were marked
differences between the distribution of NP and P in cells
infected with CPI and CPI. Thus, whilst there was
primarily a diffuse cytoplasmic distribution of NP and P in
cells infected with both CPI and CPI at 1 day p.i., by 20
days p.i. in the majority of cells infected with CPI the NP
and P proteins were located in tight cytoplasmic inclu-
sion bodies with little, if any, diffuse cytoplasmic distri-
bution of the proteins (compare magnified Figs. 6A and
6B). In contrast, although inclusion bodies could be vi-
sualised in cells infected with CPI, at 20 days p.i. the NP
and P proteins were primarily diffusely distributed
throughout the cytoplasm.
Another characteristic of murine cells infected with the
W3 strain of SV5 is that once the cells begin to produce
and respond to IFN, the cells rapidly become negative for
the virus glycoproteins whilst remaining positive for nu-
cleocapsid proteins (Young et al., 1997). To determine
whether this was the case for cells infected with CPI,
monolayers of MDCK cells were infected at 0.5 to 1.0
pfu/cell and at 12 h p.i. exogenous IFN was, or was not,
added to the culture medium. At 24 and 72 h p.i. the cells
were fixed and stained either with a mixture of anti-NP
and anti-P mAbs or with an anti-HN mAb. Although cells
infected with CPI and CPI were positive for NP/P and
HN at 24 h p.i. (data not shown) the addition of exoge-
nous IFN to the medium of cells infected with CPI
dramatically reduced the surface expression of the HN
protein by 72 h p.i. In contrast, exogenous IFN had a
much less dramatic effect on the levels of expression of
HN in CPI-infected cells at 72 h p.i. (Fig. 7).
DISCUSSION
A role for the unique cysteine-rich C-terminal domain
of the V proteins of rubulaviruses in blocking IFN signal-
ling is suggested by the observation that the C-terminal
domain alone of mumps virus can prevent IFN-induction
of an antiviral state (Kubota et al., 2001). Furthermore, a
recombinant hPIV2 virus that expresses a truncated ver-
sion of V that lacks the C-terminal domain appears to be
sensitive to IFN (Kawano et al., 2001). On the other hand,
we have also demonstrated a role for the P/V (N-termi-
nal) common domain of V in blocking IFN signalling by
demonstrating that the recombinant virus rSV5-V/P N100D,
with an asparagine to aspartic acid substitution at posi-
tion 100 in the V protein of the W3 strain, differentiates its
ability to block IFN signalling in human and murine cells
(Young et al., 2001). Here we demonstrate that mutations
in the N-terminal domain can also abolish the ability of
the V protein to block IFN signalling in cells of the natural
host species, thereby establishing a clear role for the
N-terminus of V in targeting STAT1 for degradation. In the
case of CPI, for complete loss of the ability of V to block
IFN signalling, it appears that all three mutations are
necessary. Thus, although the single L to P mutation at
position 50 adversely affects V function, the observed
inhibition is not complete. The L to P mutation at position
102, although in the same epitope recognised by the
mAb SV5-Pk (which distinguishes W3 from the murine-
adapted virus mci2 and rSV5-V/P N100D), on its own had
no clear effect on V function. However, given that it
clearly contributes to the loss of function when in com-
bination with the other mutations, it again points to this
region being critical for V function.
Whilst increased protein synthesis was observed in
cells that produce and respond to IFN infected at high
m.o.i. with CPI compared to CPI, the difference was
not as great as might have been expected. Thus, by 48 h
p.i. similar but reduced levels of virus protein synthesis
were occurring in both CPI- and CPI-infected cells
(Fig. 4). The reason(s) for this late reduction in virus
protein synthesis in CPI-infected cells remains unclear,
but these observations are similar to those in mouse
cells infected with rSV5-V/P N100D (which blocks IFN
signalling) in which there was a marked reduction in
FIG. 5. Photomicrographs demonstrating the cell-to-cell spread of CPI and CPI in MDCK cells in the presence or absence of exogenous IFN.
Cells were infected at 0.01 pfu/cell and 12 h later IFN was or was not added to the culture medium. Monolayers were fixed at 24 or 72 h p.i. and
infected cells visualised by immunofluorescence using a pool of mAbs to the NP and P proteins. For reference, some individual cells have been
highlighted with white arrows.
FIG. 6. Photomicrographs showing MDCK cells infected with CPI and CPI at 1 and 20 days following a high m.o.i. Magnified images of highlighted
areas of cells infected with CPI at 1 (A) and 20 (B) days p.i. (computer-generated conversion of red image to green for ease of visualisation) have
been included to better illustrate the accumulation of the NP and P proteins into large cytoplasmic inclusion bodies at later times p.i. in CPI-infected
cells. For reference a single cell has been highlighted with a white arrow, and in the expanded images the dark areas of two nuclei have been labelled.
FIG. 7. Photomicrographs in which CPI- (a) and CPI- (b) infected MDCK cells have been stained with either a mixture of mAbs to the NP and P
or a mAb to the HN protein. Cells were infected at an m.o.i. of 0.5 to 1.0 and at 12 h p.i. IFN was (IFN) or was not (IFN) added to the culture medium.
Monolayers were fixed at 72 h p.i. prior to immunofluorescence. For reference a single cell has been highlighted with a white arrow.
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virus protein synthesis between 48 and 72 h p.i.. Thus, it
seems unlikely that the reduction in CPI virus protein
synthesis was due to the actions of IFN but rather the
induction of an antiviral state within infected cells either
by some other cell signalling pathway, e.g., through the
activation of IRF-1, or by virus-induced inhibition (maybe
as a result of the buildup of intracellular concentration of
NP and the switch from virus transcription to replication).
However, clear biological differences in the way CPI
and CPI respond to IFN were observed in that CPI
spread from cell to cell much more readily than CPI in
the presence of exogenous IFN. Nevertheless even
though CPI blocked IFN signalling, exogenous IFN sig-
nificantly reduced the speed of spread of CPI from cell
to cell. This is because cells, once in their IFN-induced
antiviral state, clearly suppress CPI replication. How-
ever, we have previously shown that even in cells in an
IFN-induced antiviral state STAT1 is degraded and even-
tually the cells go out of their antiviral state and normal
levels of virus proteins are synthesised (Didcock et al.,
1999b).
It seems reasonable to assume that one of the rea-
sons that CPI is more pathogenic than CPI (Baumgart-
ner et al., 1991) is its ability to block IFN signalling. Thus,
the isolation of the IFN-sensitive virus (CPI) from an
animal 12 days after infection with CPI seems counter-
intuitive but may reflect an evolutionary adaptation by the
virus to the development of acquired immune responses.
Whereas cells infected with the IFN-resistant CPI would
continue to synthesise virus proteins in the presence of
IFN and become ready targets for killing by cytotoxic T
cells or antibody-mediated killing, cells infected with the
IFN-sensitive CPI would exhibit impaired viral protein
synthesis. Thus in cells infected with CPI, viral nucleo-
capsids together with aggregates of NP and P would
accumulate in stable cytoplasmic inclusion bodies, virus
glycoproteins would be lost from the surface of infected
cells, and consequently the cells may become hidden
from adaptive immune responses (Fearns et al., 1994;
Precious et al., 1995; Young et al., 1997).
If the selection of IFN-sensitive viruses, such as CPI,
generally occurs as the adaptive immune response de-
velops, this may be one way in which certain paramyxo-
viruses establish persistent infections in vivo. Even if
most cells harbouring IFN-sensitive viruses were elimi-
nated, a few cells harbouring IFN-sensitive virus in a
repressed state may survive until the acute immune
response and inflammation dampens down. Presumably,
and as we have previously shown (Young et al., 1997), the
IFN-sensitive viruses would then flux between active and
repressed states in response to local production of IFN.
During active replication of IFN-sensitive viruses rever-
tant viruses could once again be generated which are
resistant to IFN, and in the absence of an acute immune
reaction, these IFN-resistant revertants may then repli-
cate and spread to a limited extent (before being con-
trolled by a rapid secondary immune response but per-
haps in the absence of overt disease) such that enough
virus might be liberated into the environment to infect
susceptible individuals. Alternatively, small amounts of
IFN-sensitive viruses that might occasionally be liber-
ated by persistently infected individuals may infect non-
immune individuals and establish limited infections. Sub-
sequently, IFN-resistant revertants may be selected lead-
ing to increased virus spread within these individuals.
This may or may not result in clinical disease, depending
upon the speed of induction of the adaptive immune
response compared to that of virus dissemination.
Whilst this model is dependent upon the selection of
point mutations in the V gene, it is worth noting that it is
already accepted that the survival of many RNA viruses
in nature is dependent upon the selection of point mu-
tations, e.g., to generate antigenic variation to escape
from neutralising antibodies. The model is also consis-
tent with the known ability of SV5 to establish persistent
infections in monkeys, with the virus regularly recover-
able from kidney cell cultures generated long after the
animals were infected (Tribe, 1966; Atoynatan and Hsi-
ung, 1969; Hsiung, 1972; Randall and Russell, 1991).
Thus, specific selection of IFN-resistant and IFN-sen-
stive viruses depending on the state of the adaptive
immune response offers one possible way in which RNA
viruses could establish persistent infection; in this model
viruses not only circumvent the IFN response, but also
use it to their own advantage.
METHODS
Cells, viruses, and interferon
Human 2fTGH cells (Pellegrini et al., 1989), canine
MDCK cells, and murine BF cells (Balb/c mouse embryo
fibroblasts) were cultured as monolayers in 25- or 75-cm2
tissue culture flasks, in Dulbecco’s modified Eagle’s me-
dium supplemented with 10% foetal calf serum (growth
medium). All cell lines were negative for mycoplasmas
as screened by DAPI staining. Human cells and murine
cells were treated with recombinant human interferon-
A/D (rHuIFN-A/D) (Rehberg et al., 1982) at 1000 IU/ml.
Canine cells were treated with interferon produced by
infecting MDCK cells with SV5, collecting the medium at
24 h p.i., and inactivating the virus with UV light prior to
pelleting of the virus by centrifugation at 100,000 g for 30
min. The amount of canine IFN in the medium was
quantitated by a luciferase reporter assay, rather than by
its ability to inhibit EMC virus. The amount of IFN used in
the assays described was 16 times greater than the
minimum amount which would activate the IFN-respon-
sive plasmid. In the equivalent tests with human IFN-
this would be equivalent to 100 IU/ml. SV5 strains W3A
(Choppin, 1964), CPI (78-238), and CPI (Baumga¨rtner
et al., 1981, 1982, 1987) were grown and titrated under
appropriate conditions in Vero cells.
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Plasmid DNAs and site-directed mutagenesis
The IFN-/-responsive plasmid [termed p(9-27)-
4tk(39)lucter] contained four tandem repeat se-
quences of the ISRE from the IFN-inducible gene, 9-27,
fused to the firefly luciferase gene (King and Goodbourn,
1998). pJATlacZ, a plasmid used as a transfection stan-
dard, contains a -galactosidase gene under the control
of the rat -actin promoter (Masson et al., 1992). The
construction of the plasmid pEF.SV5-V (here termed
pEF.W3/V as the V gene was derived from the W3 strain
of SV5) has been reported elsewhere (Didcock et al.,
1999b) The pEF.W3/CPI/V and pEF.W3/CPI/V plasmids
were constructed by PCR amplifation of the P/V genes
from CPI- and CPI-infected cells, cleaving the prod-
ucts with BamHI, and using the respective fragments to
replace the BamHI fragment in pEF.W3/V as outlined in
Fig. 2. The single and double point mutations that differ-
entiate CPI from CPI were reintroduced into pEF.W3/
CPI/V by PCR mutagenesis. For transfections, monolay-
ers of cells grown in six-well plates to 50–70% conflu-
ence were transfected with 1 g of the appropriate DNA
and 1.5 l of Fugene 6 (Roche) according to the manu-
facturer’s instructions.
Preparation of radiolabelled antigen extracts,
immunoprecipitation, and SDS–PAGE
MDCK cell monolayers in six-well tissue culture plates
were infected with CPI or CPI (or mock infected) and
the inoculum was adsorbed for 1 h. At various times
p.i. (see text) cells were metabolically labelled with
L-[35S]methionine (500Ci/mmol; Amersham International
Ltd., UK) in methionine-free tissue culture medium for
2 h. At the end of the labelling interval, the cells were
washed in ice-cold PBS and lysed into immune precipi-
tation buffer (10 mM Tris–HCl, pH 7.8, 5 mM EDTA, 0.5%
Nonidet P-40, and 0.65 M NaCl; 4  106 to 6  106 cells
per millilitre of buffer) by sonication with an ultrasonic
probe. Soluble antigen extracts were obtained after pel-
leting the particulate material from the total cell antigen
extracts by centrifugation at 400,000 g for 30 min. Im-
mune complexes were formed by incubating (for 2 h at
4°C) 0.2- to 1-ml samples of the soluble antigen extracts
with an excess of anti-SV5 mAbs to the HN, F, P, M, and
NP proteins (1 l of concentrated tissue culture fluid of
mAbs SV5-HN-4a, NP-a, P-e, M-h, or F-1a; Randall et al.,
1987). The immune complexes were isolated using an
excess of protein G–Sepharose 4B Fast Flow (Sigma; 20
l of a 50% w/v suspension per microliter of concen-
trated tissue culture fluid for 1 h at 4°C). The proteins in
the immune complexes were dissociated by heating
(100°C for 5 min) in gel electrophoresis sample buffer
(0.05 M Tris–HCl, pH 7.0, 0.2% SDS, 5% 2-mercaptoetha-
nol, and 5% glycerol) and subjected to SDS–PAGE. After
electrophoresis gels were fixed, stained, and dried, la-
belled polypeptides were visualised by phosphorimager
analysis.
Immunoblotting
Immediately prior to harvesting, cells were washed
twice with PBS and lysed into gel electrophoresis sam-
ple buffer. The cell lysates were then processed by
sonication and heating at 100°C for 5 min. The samples
were subjected to SDS–PAGE, polypeptides were trans-
ferred to nitrocellulose membranes, and STAT1 was de-
tected using a polyclonal anti-STAT1 antibody raised
against the amino-terminal 194 amino acids of the pro-
tein (Transduction Laboratories; Cat. No. G16930). The
protein–antibody interactions were visualised by en-
hanced chemiluminescence using horseradish peroxi-
dase-conjugated donkey anti-rabbit IgG (Amersham In-
ternational Ltd., UK).
Immunofluorescence
Cells to be stained for immunofluorescence were
grown on 10-mm-diameter coverslips (General Scientific
Co. Ltd., UK) and then treated and stained with specific
mAbs, as described previously (Randall and Dinwoodie,
1986). The antibody–antigen interactions were detected
by indirect immunofluorescence using a secondary anti-
mouse Ig Texas red-conjugated antibody (Seralab, UK;
Cat. No. SBA 1010-02). The primary antibodies used to
detect the HN, P, and NP were SV5-HN-4a, SV5-P-e, and
SV5-NP-a, respectively (Randall et al., 1987). The treated,
stained monolayers were examined for immunofluores-
cence using a Nikon Microphot-FXA fluorescence micro-
scope.
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